AstraZeneca has now joined Pfizer in agreeing to sell its drugs to state Medicaid programs at “most-favored-nation” pricing and deeply discounted rates on TrumpRx.gov ...

Ulbrich discussed navigating uncertainty, the evolution of central business districts, and return to office mandates.

President Trump at 5p ET Friday will say that AstraZeneca has made a deal with the Trump administration to cut the prices of ...

GoodRx, an online platform that offers drug discount coupons to patients, is in talks with the government to participate in ...

President Donald Trump’s attack on drug costs is more likely to deprive Europeans of some medicines rather than lower prices in the US, according to the former boss of Novo Nordisk A/S.

U.S. drugmaker Pfizer Inc is hoping to rapidly roll out its experimental COVID-19 vaccine around Latin America soon after it gets emergency authorization in the United States, a senior executive said, ...

Pfizer Inc's experimental COVID-19 vaccine is more than 90% effective based on initial trial results, the drugmaker said on Monday, a major victory in the war against a virus that has killed over a ...

Pfizer only offered to discount six products through the Most Favored Nation program, and healthcare policy experts suggest ...

In this week’s edition of InnovationRx, we look at the Haitian immigrant who built a $6 billion company treating brain ...

Newly launched Pfizer drugs will be priced at parity to prices in comparable developed nations, according to the most-favored ...

During an announcement of TrumpRx, a direct-to-consumer website allowing Americans to purchase prescription drugs at a ...

Arvinas saw a steep stock price drop after Pfizer decided to stop developing a breast cancer drug with the New Haven–based firm. CEO John Houston told the News about the company’s plans for the future ...